<DOC>
	<DOCNO>NCT02805283</DOCNO>
	<brief_summary>The purpose study evaluate diabetes related treatment satisfaction patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Dapagliflozin Patient Satisfaction Survey</brief_title>
	<detailed_description>This cross-sectional , observational patient survey study . Study subject adult commercial member large US health plan affiliate Optum evidence T2D initiate dapagliflozin sulfonylurea medication within 3 month prior survey mailing .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>At least one pharmacy claim dapagliflozin dapagliflozin/metformin ER recent month pharmacy data pharmacy claim SGLT2 medication 6 month prior sample identification . Evidence T2D diagnosis . Age â‰¥18 drug index date . 6 month continuous enrollment commercial health plan pharmacy medical benefit identification period patient interview sample identification date . Selfreported T2D diagnosis patient interview . Patients evidence type 1 diabetes mellitus unknown type Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Diabetes Mellitus , Type 2</keyword>
</DOC>